Mesenchymal Chondrosarcoma in the Maxilla: A Case Report and Literature Review.

J Oral Maxillofac Surg

Associate Professor, Division of Oral and Maxillofacial Pathology, Columbia University Irving Medical Center, New York City, NY.

Published: August 2021

Mesenchymal chondrosarcoma is a rare high-grade variant of chondrosarcoma distinguished by its aggressive nature. Molecular studies aid in establishing the diagnosis. We present a case report of mesenchymal chondrosarcoma in the maxilla of a 39-year-old male patient and a literature review of 42 gnathic cases of mesenchymal chondrosarcoma with a discussion of clinical, imaging, microscopic, immunohistochemical, and molecular features.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2021.02.020DOI Listing

Publication Analysis

Top Keywords

mesenchymal chondrosarcoma
16
chondrosarcoma maxilla
8
case report
8
literature review
8
mesenchymal
4
maxilla case
4
report literature
4
review mesenchymal
4
chondrosarcoma
4
chondrosarcoma rare
4

Similar Publications

A rare case of rib chondrosarcoma with purely mesenchymal cells metastases to thyroid.

Diagn Pathol

March 2025

Department of pathology, Peking University Third Hospital, Haidian District, 49 North Garden Road, Beijing, 100191, China.

Metastasis to the thyroid gland is uncommon. The most common malignant tumors that metastasize to the thyroid gland include renal cell carcinoma, colorectal cancer, lung cancer, and breast cancer. Metastasis of chondrosarcoma to thyroid is extremely rare.

View Article and Find Full Text PDF

Chondrosarcoma: New Molecular Insights, Challenges in Near-Patient Preclinical Modeling, and Therapeutic Approaches.

Int J Mol Sci

February 2025

Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Chondrosarcoma (CS), the second most common malignant bone tumor after osteosarcoma, accounts for 20-30% of all malignant bone tumors. It mainly affects adults, middle-aged, and elderly people. The CS family includes various entities displaying peculiar biological, genetic, and epigenetic characteristics and clinical behaviors.

View Article and Find Full Text PDF

Application of patient derived xenograft model in personalized drug screening for chondrosarcoma of head and neck: A preclinical study.

Oral Oncol

March 2025

State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Department of Head and Neck Oncology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China. Electronic address:

Objectives: The effect of radiotherapy and chemotherapy on head and neck chondrosarcoma (HNCS) has not been unanimously determined because of the rarity of HNCS. Patient-Derived Xenograft (PDX) model is considered to be a good preclinical model for new drug development and personalized drug screening. We performed this study to investigate the preclinical application and value of PDX model in drug screening for HNCS.

View Article and Find Full Text PDF

Cytogenomic Characterization of Murine Cell Line Sarcoma 180 = S-180.

Int J Mol Sci

January 2025

Croatian Institute for Brain Research, School of Medicine University of Zagreb, Salata 12, 10000 Zagreb, Croatia.

The cell line Sarcoma 180, which is also called S-180 (or S180), was established about 110 years ago from a murine axillary sarcoma. It has been applied in >5000 studies but was never genetically characterized in detail; this study fills that gap. The cell line Sarcoma 180 was analyzed for its chromosomal constitution using molecular cytogenetic approaches, specifically murine multicolor banding (mcb).

View Article and Find Full Text PDF

Dedifferentiated liposarcoma (DDLPS) is a subtype of LPS characterized by two distinct levels of differentiation and morphological structures, comprising areas of well-differentiated LPS and dedifferentiated, non-lipogenic, highly malignant components. DDLPS most frequently occurs in the retroperitoneum and the soft tissues of the pelvis and limbs, and is rare in the head and neck region, accounting for only 1% of head and neck sarcomas. The present study describes the case of a 72-year-old male with a 30-year history of left upper limb numbness and heaviness.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!